ARNA Related Hot List
-
Arena (ARNA), Eisai win FDA approval for diet pill lorcaserin
-
Arena (ARNA) Shares Resume Trading Down 40% as FDA Panel Won't Back Lorcaserin
-
Arena Pharmaceutical (ARNA) Reports Q3 Loss, Lowers 2006 Revenue Outlook
-
Arena Pharmaceuticals (ARNA) Says Merck (MRK) to Discontinue Development of MK-0354
-
Arena Pharmaceuticals (ARNA) Tops Q1 EPS by $0.06
-
ARNA Higher After Positive Trial Results
-
ARNA Announces Positive Phase II Trial For Weight Loss Drug
Back to ARNA Stock Lookup
